Table 1.
Human KD | CAWS | LCWE | |
---|---|---|---|
Pathogenesis | Unknown | Superantigen | Superantigen |
Etiology | Unknown | Candida albicans water soluble injection | Lactobacillus casei cell wall extract injection |
Animal | Human | Mice | Mice |
Arteritis | medium-sized, muscular arteries, includes epicardial coronary arteries |
Targets elastic arteries, including aortic root | Elastic arteries, aortitis, proximal coronary arteritis, abdominal aorta dilatations. |
Histology | Early neutrophils, mixed data on granulomas | Monocytes, macrophages, neutrophils | Granulomatous |
Myocarditis | Subclinical, Tachycardia |
Significant | Significant, CK-MB and troponin rise, late myofibrosis |
Timing | Adventia/intima to pan vasculitis | Progresses from initial intima layer slowly to panvasculitis | np |
Therapy that reduces coronary inflammation | IVIG shows efficacy, Cyclosporine A efficacious in higher risk individuals | TNF a blocks arteritis IVIG partially blocks arteritis IVIG timing influences effect |
Diminished by IVIG, anti-TNFα, anti-IL-1 |
Long term findings | Unclear associations Limited pathologic samples, mixed reports |
np | Atherosclerosis, myofibrosis |
np, not published.